| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 200 |
| 1 | OMEPRAZOLE MAGNESIUM | 105 |
| 2 | VALSARTAN | 105 |
| 3 | METHOTREXATE SODIUM | 101 |
| 4 | PANTOPRAZOLE | 97 |
| 5 | AMLODIPINE | 96 |
| 6 | ASPIRIN | 95 |
| 7 | METHOTREXATE | 90 |
| 8 | ASPIRIN 325 MG | 88 |
| 9 | ASPIRIN 81 MG | 88 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ASCORBIC ACID | 1 | 0.0625 |
| 1 | METHAZOLAMIDE | 13 | 0.0377 |
| 2 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 3 | MAGESIUM CITRATE | 1 | 0.0109 |
| 4 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 4 | 0.0101 |
| 5 | LULICONAZOLE | 1 | 0.0057 |
| 6 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 7 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 8 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 9 | PAMABROM | 1 | 0.0027 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 218 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 205 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 198 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 147 |
| 4 | Proton Pump Inhibitor [EPC] | 134 |
| 5 | Kinase Inhibitor [EPC] | 111 |
| 6 | Benzodiazepine [EPC] | 103 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 102 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 98 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 97 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 1 | Provitamin D2 Compound [EPC] | 94 | 0.0032 |
| 2 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 5 | Typical Antipsychotic [EPC] | 24 | 0.0010 |
| 6 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 7 | Interleukin-17A Antagonist [EPC] | 30 | 0.0008 |
| 8 | Leptin Analog [EPC] | 1 | 0.0008 |
| 9 | Human C1 Esterase Inhibitor [EPC] | 3 | 0.0008 |